Eosinophilic asthma is a subtype of asthma characterized by high levels of eosinophils in the airways, leading to chronic inflammation and symptoms like wheezing, coughing, and shortness of breath.
Eosinophilic Asthma
Hightower Clinical aimed to find better treatments for eosinophilic asthma to help you breathe easy, live better.
Eosinophilic Asthma Study
Eosinophilic asthma is a severe form of asthma caused by elevated levels of eosinophils, a type of white blood cell that leads to airway inflammation. This inflammation can cause persistent symptoms like wheezing, coughing, chest tightness, and shortness of breath, significantly affecting quality of life. The clinical trial investigated the safety, tolerability, and efficacy of an experimental medication designed to manage the symptoms and improve lung function and find better treatments for eosinophilic asthma.
Current Status
Not Recruiting
Study Count
02
Study Information
Eosinophilic Asthma
| Study Name | Protocol Number | Sponsor |
|---|---|---|
| Eosinophilic Asthma | AR-DEX-22-02 | Areteia Therapeutics |
AR-DEX-22-03 | Areteia Therapeutics |
Frequently Asked Questions
What is the goal of the eosinophilic asthma study?
This study aimed to evaluate the safety, tolerability, and effectiveness of an investigational drug in reducing asthma symptoms and improving lung function in individuals with severe eosinophilic asthma.
How do I know if I’m eligible to participate?
To determine your eligibility, complete the form provided, and a member of our research team will contact you to discuss your medical history, symptoms, and other criteria for participation.
Unlock New Opportunities in Clinical Research - Join Today!
We're here and eager to assist. Reach out to Hightower Clinical Research in Oklahoma City, OK for further details on how we can support you.
Get Involved Today!
© Copyright 2024 – Hightower Clinical. CREATED BY DIGITAL AUXILIUS.